- Randomized trial of cyclophosphamide, methotrexate, and fluorouracil chemotherapy added to tamoxifen as adjuvant therapy in postmenopausal women with node-positive estrogen and/or progesterone receptor-positive breast cancer: a report of the National Cancer Institute of Canada Clinical Trials Group. Breast Cancer Site Group. Pritchard, K.I., Paterson, A.H., Fine, S., Paul, N.A., Zee, B., Shepherd, L.E., Abu-Zahra, H., Ragaz, J., Knowling, M., Levine, M.N., Verma, S., Perrault, D., Walde, P.L., Bramwell, V.H., Poljicak, M., Boyd, N., Warr, D., Norris, B.D., Bowman, D., Armitage, G.R., Weizel, H., Buckman, R.A. J. Clin. Oncol. (1997)